Atossa Therapeutics
ATOS
#10745
Rank
C$28.67 M
Marketcap
C$2.87
Share price
2.55%
Change (1 day)
159.40%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2026 (TTM): C-$5.69

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is C-$5.85. In 2025 the company made an earnings per share (EPS) of C-$5.78 a decrease over its 2024 EPS that were of C-$4.35.

EPS history for Atossa Therapeutics from 2010 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$5.69-1.53%
2025C-$5.7832.89%
2024C-$4.35-15.56%
2023C-$5.1514.29%
2022C-$4.5016.67%
2021C-$3.86-90.86%
2020C-$42.25-2.96%
2019C-$43.54-63.09%
2018C-$117.96-49.63%
2017C-$234.20-57.87%
2016C-$555.91-74.01%
2015C-$2,139-9.18%
2014C-$2,355-12.86%
2013C-$2,70270.73%
2012C-$1,58334.07%
2011C-$1,181263.41%
2010C-$324.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.55-263.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
C$14.56-348.90%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$17.54-400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
C-$0.36-93.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
C-$0.30-94.87%๐Ÿ‡บ๐Ÿ‡ธ USA